Interatrial block in prediction of all-cause mortality after first-ever ischemic stroke.
All-cause mortality
Atrial fibrosis
ECG
Interatrial block
Ischemic stroke
Journal
BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539
Informations de publication
Date de publication:
11 02 2019
11 02 2019
Historique:
received:
30
10
2018
accepted:
04
02
2019
entrez:
13
2
2019
pubmed:
13
2
2019
medline:
18
12
2019
Statut:
epublish
Résumé
Interatrial block (IAB) is an ECG indicator of atrial fibrosis related to atrial remodeling and thrombus formation thus leading to embolic stroke and increasing mortality. We aimed to assess weather IAB predicted all-cause mortality during 10 years after ischemic stroke. The study sample comprised 235 patients (median age 74 (interquartile range 25-75% 65-81) years, 95 female) included in the Lund Stroke Register in 2001-2002, who had sinus rhythm ECGs at stroke admission. IAB was defined as a P-wave duration ≥120 ms without = partial IAB (n = 56) or with = advanced IAB (n = 41) biphasic morphology (±) in the inferior ECG leads. All-cause mortality was assessed via linkage with the Swedish Causes of Death Register. During follow-up 126 patients died (54%). Advanced IAB, but not partial, was associated with all-cause mortality in univariate Cox regression analysis (hazard ratio (HR) 1.98, 95% CI 1.27-3.09, p = 0.003). After adjustment for age, gender, severity of stroke measured by NIHSS scale and smoking status in patients without additional comorbidities advanced IAB independently predicted all-cause mortality (HR 7.89, 95% CI 2.01-30.98, p = 0.003), while in patients with comorbidities it did not (HR 1.01 95% CI 0.59-1.72, p = 0.966). Advanced IAB predicted all-cause mortality after ischemic stroke, but mostly in patients without additional cardiovascular comorbidities.
Sections du résumé
BACKGROUND
Interatrial block (IAB) is an ECG indicator of atrial fibrosis related to atrial remodeling and thrombus formation thus leading to embolic stroke and increasing mortality. We aimed to assess weather IAB predicted all-cause mortality during 10 years after ischemic stroke.
METHODS
The study sample comprised 235 patients (median age 74 (interquartile range 25-75% 65-81) years, 95 female) included in the Lund Stroke Register in 2001-2002, who had sinus rhythm ECGs at stroke admission. IAB was defined as a P-wave duration ≥120 ms without = partial IAB (n = 56) or with = advanced IAB (n = 41) biphasic morphology (±) in the inferior ECG leads. All-cause mortality was assessed via linkage with the Swedish Causes of Death Register.
RESULTS
During follow-up 126 patients died (54%). Advanced IAB, but not partial, was associated with all-cause mortality in univariate Cox regression analysis (hazard ratio (HR) 1.98, 95% CI 1.27-3.09, p = 0.003). After adjustment for age, gender, severity of stroke measured by NIHSS scale and smoking status in patients without additional comorbidities advanced IAB independently predicted all-cause mortality (HR 7.89, 95% CI 2.01-30.98, p = 0.003), while in patients with comorbidities it did not (HR 1.01 95% CI 0.59-1.72, p = 0.966).
CONCLUSION
Advanced IAB predicted all-cause mortality after ischemic stroke, but mostly in patients without additional cardiovascular comorbidities.
Identifiants
pubmed: 30744701
doi: 10.1186/s12872-019-1015-5
pii: 10.1186/s12872-019-1015-5
pmc: PMC6371419
doi:
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
37Références
Acta Neurol Scand. 2014 Jun;129(6):412-9
pubmed: 24299072
Am J Cardiol. 2016 Jun 1;117(11):1755-9
pubmed: 27072646
Continuum (Minneap Minn). 2017 Feb;23(1, Cerebrovascular Disease):15-39
pubmed: 28157742
Neurology. 2016 Jul 26;87(4):352-6
pubmed: 27343071
J Electrocardiol. 2012 Sep;45(5):445-51
pubmed: 22920783
Herzschrittmacherther Elektrophysiol. 2018 Mar;29(1):62-69
pubmed: 29392412
Age (Dordr). 2009 Mar;31(1):27-38
pubmed: 19234766
Stroke. 1999 Aug;30(8):1534-7
pubmed: 10436096
Eur Heart J. 1988 Oct;9(10):1112-8
pubmed: 3208776
Ann Noninvasive Electrocardiol. 2017 Jan;22(1):
pubmed: 27982498
BMC Cardiovasc Disord. 2017 Jul 31;17(1):211
pubmed: 28760133
J Am Coll Cardiol. 2011 Feb 15;57(7):831-8
pubmed: 21310320
Heart Rhythm. 2011 Jan;8(1):93-100
pubmed: 20868770
Int J Cardiol. 2017 Apr 1;232:134-139
pubmed: 28132778
J Electrocardiol. 2018 Jan - Feb;51(1):1-7
pubmed: 28969847
Int J Cardiol. 2010 May 14;141(1):18-23
pubmed: 19144430
Thromb Haemost. 2018 May;118(S 01):S34-S44
pubmed: 29566416
Heart Rhythm. 2016 Mar;13(3):645-51
pubmed: 26520207
Ann Noninvasive Electrocardiol. 2010 Jan;15(1):63-72
pubmed: 20146784